You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Advancing a Mucosal HSV-2 Vaccine Towards Clinical Trials

    SBC: Biomedical Research Models, Inc.            Topic: NIAID

    DESCRIPTION (provided by applicant): Globally, an estimated 16.2% of the human population is infected with HSV-2 including gt17% of the U.S. adult population. Genital herpes is associated with an increased risk of HIV acquisition and transmission and HSV-2infection can cause neonatal herpes with high infant mortality. HSV-2 infection in the adult population has increased substantially in the past ...

    SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  2. Commercialization of the Shutter-Speed Model for Dynamic MRI in Cancer Diagnosis

    SBC: Imbio, LLC            Topic: 102

    DESCRIPTION provided by applicant Despite remarkable advances in cancer detection and treatment the disease continues to be a leading cause of mortality in the US accounting for of all deaths in Cancer of the breast and prostate are by far the most common forms diagnosed in US women and men respectively and together are expected to represent more than prostate ...

    SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  3. DMX: Enabling Blind Source Separation for Hearing Health Care

    SBC: Speech Technology and Applied Research Corporation            Topic: NIDCD

    DESCRIPTION provided by applicant Typical biological environments comprise complex mixtures of signals from multiple biological and environmental sources Some sources contain critical information that researchers seek to acquire other sources are distractions that interfer with data acquisition Common acoustic environments are an important example a significant segment of the aging US popul ...

    SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  4. Motivational Interviewing: An Experiential Online Training Tool

    SBC: C4 Innovations, LLC            Topic: 104

    DESCRIPTION provided by applicant Between and the Center for Social Innovation LLC C developed and evaluated a prototype of the Motivational Interviewing Simulator An Experiential Online Training Tool The interactive case based multiplayer web based game allows service providers to deepen their skills in Motivational Interviewing MI a widely recognized evidence based prac ...

    SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  5. Dashboards for Clinician Monitoring of Patients Through a Mobile Sensing Platform

    SBC: COGITO HEALTH, INC.            Topic: 104

    DESCRIPTION provided by applicant Mental health disorders exact very high personal social and economic costs in our country and around the world presenting a significant public health challenge Clinicians and researchers are currently faced with the difficult task of inferrig patient behavior and treatment adherence between clinic visits through self report and historical behavior Cogitoan ...

    SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  6. Biological vector control reducing arboviruses, including Dengue and Chikungunya

    SBC: MosquitoMate, Inc            Topic: NIAID

    DESCRIPTION provided by applicant In the absence of effective approved drugs or vaccines vector control remains the only means of intervention for many against mosquito borne diseases This problem grows more complex with the recent establishment of multiple exotic mosquito species and mosquito borne pathogens Furthermore changing climate conditions are predicted to alter the traditional ra ...

    SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  7. Novel spectinamide antibiotics for the treatment of MDR/XDR tuberculosis

    SBC: MICROBIOTIX, INC.            Topic: NIAID

    DESCRIPTION provided by applicant The overall objective of this project is to develop a novel chemical class of tuberculosis TB therapeutic agents the spectinamide series for use against MDR and XDR strains of Mycobacterium tuberculosis Mtb and identify through a series of in vivo efficacy assays and preclinical pharmacokinetics toxicology and safety pharmacology studies a clinical can ...

    SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  8. Rapid Test for Recent HIV Infection

    SBC: IMMUNETICS, INC.            Topic: R

    DESCRIPTION provided by applicant Monitoring the HIV epidemic to understand rates and patterns of growth as well as targeting intervention efforts to populations exhibiting high rates f HIV transmission are wholly dependent on determining the frequency of new infections using an assay that discriminates recent from long term HIV infection However very few HIV assays have been developed spec ...

    SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  9. Rapid point of care test for Lyme serodiagnosis based on novel ultra sensitive de

    SBC: IMMUNETICS, INC.            Topic: NIAID

    DESCRIPTION provided by applicant Lyme disease is the most prevalent vector borne disease in the U S with about cases per year reported by CDC and a range now covering states Early diagnosis and treatment of Lyme disease is important to prevent the disease from progressing to a systemic infection characterized by chronic arthritis carditis or neurological disorders Where a patien ...

    SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  10. Novel method to create knockout rats using endonucleases and spermatogonial stem

    SBC: TRANSPOSAGEN BIOPHARMACEUTICALS, INC.            Topic: 200

    DESCRIPTION provided by applicant The laboratory rat is a preferred rodent model in pre clinical drug studies Their larger size facilitates procedures otherwise difficult in mice includng studies using instrumentation blood sampling and surgeries and allows for ten times the amount of tissue collection Although rats are often more suitable than mice for pharmacological toxicological phy ...

    SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government